Doyle John Brendan Insider Trades

Insider Trading History

Track insider trading activity for Doyle John Brendan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cognition Therapeutics
Cognition Therapeutics CGTX
Chief Financial Officer
Holding Value $879k 618,942 shares
Last Trade
May 01, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11k 8,567 shares
$1.28
$1.42
Cognition Therapeutics
Cognition Therapeutics CGTX
Chief Financial Officer
Holding Value $891k 627,509 shares
Last Trade
Apr 16, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.3k 10,000 shares
$1.13
$1.42
Cognition Therapeutics
Cognition Therapeutics CGTX
Chief Financial Officer
Holding Value $877k 617,509 shares
Last Trade
Feb 15, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.75k 1,560 shares
$1.12
$1.42
Cognition Therapeutics
Cognition Therapeutics CGTX
Chief Financial Officer
Holding Value $879k 619,069 shares
Last Trade
Feb 04, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$27.7k 26,921 shares
$1.03
$1.42
Cognition Therapeutics
Cognition Therapeutics CGTX
Chief Financial Officer
Holding Value $917k 645,990 shares
Last Trade
Feb 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$228k 200,000 shares
$1.14
$1.42
Cognition Therapeutics
Cognition Therapeutics CGTX
Chief Financial Officer
Holding Value $647k 455,350 shares
Last Trade
Dec 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45k 30,000 shares
$1.50
$1.42
Cognition Therapeutics
Cognition Therapeutics CGTX
Chief Financial Officer
Holding Value $633k 445,990 shares
Last Trade
Dec 18, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14k 9,360 shares
$1.50
$1.42
Cognition Therapeutics
Cognition Therapeutics CGTX
Chief Financial Officer
Holding Value $617k 434,710 shares
Last Trade
Jul 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.1k 30,000 shares
$0.67
$1.42
Cognition Therapeutics
Cognition Therapeutics CGTX
Chief Financial Officer
Holding Value $604k 425,350 shares
Last Trade
Jul 29, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.27k 9,360 shares
$0.67
$1.42
Cognition Therapeutics
Cognition Therapeutics CGTX
Chief Financial Officer
Holding Value $575k 404,710 shares
Last Trade
May 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.36k 9,692 shares
$0.45
$1.42
Cognition Therapeutics
Cognition Therapeutics CGTX
Chief Financial Officer
Holding Value $588k 414,402 shares
Last Trade
Feb 15, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.02k 1,723 shares
$0.59
$1.42
Cognition Therapeutics
Cognition Therapeutics CGTX
Chief Financial Officer
Holding Value $591k 416,125 shares
Last Trade
Feb 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$185k 295,000 shares
$0.63
$1.42
Cognition Therapeutics
Cognition Therapeutics CGTX
Chief Financial Officer
Holding Value $172k 121,125 shares
Last Trade
May 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$17k 8,699 shares
$1.95
$1.42
Cognition Therapeutics
Cognition Therapeutics CGTX
Chief Financial Officer
Holding Value $184k 129,824 shares
Last Trade
Feb 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.6k 20,000 shares
$1.98
$1.42
Cognition Therapeutics
Cognition Therapeutics CGTX
Chief Financial Officer
Holding Value $156k 109,824 shares
Last Trade
May 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$362k 219,648 shares
$1.65
$1.42
Chiasma
Chiasma CHMA
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Aug 05, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$691k 175,000 shares
$3.95
$3.76
Chiasma
Chiasma CHMA
Chief Financial Officer
Holding Value $658k 175,000 shares
Last Trade
Jan 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$691k 175,000 shares
$3.95
$3.76

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up